Radretumab (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Radretumab" in English language version.

refsWebsite

Global rank English rank

1web.archive.org

1^st place

1^st place

low place

low place

195^th place

302^nd place

2^nd place

2^nd place

4^th place

4^th place

1semanticscholar.org

11^th place

8^th place

doi.org (Global: 2^nd place; English: 2^nd place)

Erba PA, Sollini M, Orciuolo E, Traino C, Petrini M, Paganelli G, Bombardieri E, Grana C, Giovannoni L, Neri D, Menssen HD, Mariani G (June 2012). "Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies". Journal of Nuclear Medicine. 53 (6): 922–7. doi:10.2967/jnumed.111.101006. PMID 22577235. S2CID 26518175.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Erba PA, Sollini M, Orciuolo E, Traino C, Petrini M, Paganelli G, Bombardieri E, Grana C, Giovannoni L, Neri D, Menssen HD, Mariani G (June 2012). "Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies". Journal of Nuclear Medicine. 53 (6): 922–7. doi:10.2967/jnumed.111.101006. PMID 22577235. S2CID 26518175.

philogen.com (Global: low place; English: low place)

"Radretumab (L19-131I)". Philogen. Archived from the original on 6 November 2017.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Erba PA, Sollini M, Orciuolo E, Traino C, Petrini M, Paganelli G, Bombardieri E, Grana C, Giovannoni L, Neri D, Menssen HD, Mariani G (June 2012). "Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies". Journal of Nuclear Medicine. 53 (6): 922–7. doi:10.2967/jnumed.111.101006. PMID 22577235. S2CID 26518175.

web.archive.org (Global: 1^st place; English: 1^st place)

"Radretumab (L19-131I)". Philogen. Archived from the original on 6 November 2017.

who.int (Global: 195^th place; English: 302^nd place)

World Health Organization (2010). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 104" (PDF). WHO Drug Information. 24 (4).